Cart
sales@molnova.com
Senktide
CAS No. 106128-89-6
Senktide( —— )
Catalog No. M21173 CAS No. 106128-89-6
Senktide is an agonist of tachykinin NK3 receptor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 123 | In Stock |
|
| 10MG | 187 | In Stock |
|
| 25MG | 312 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameSenktide
-
NoteResearch use only, not for human use.
-
Brief DescriptionSenktide is an agonist of tachykinin NK3 receptor.
-
DescriptionSenktide is an agonist of tachykinin NK3 receptor.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayGPCR/G Protein
-
TargetNeurokinin Receptor
-
RecptorNK3
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number106128-89-6
-
Formula Weight842
-
Molecular FormulaC40H55N7O11S
-
Purity>98% (HPLC)
-
SolubilityDMSO:50 mg/mL (59.38 mM; Need ultrasonic)
-
SMILESCSCCC(NC(=O)C(CC(C)C)NC(=O)CNC(=O)C(Cc1ccccc1)N(C)C(=O)C(Cc1ccccc1)NC(=O)C(CC(=O)O)NC(=O)CCC(=O)O)C(N)=O
-
Chemical Name(5S8S14S17S20S)-1417-dibenzyl-5-carbamoyl-20-(carboxymethyl)-8-isobutyl-15-methyl-71013161922-hexaoxo-2-thia-6912151821-hexaazapentacosan-25-oic acid
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Keegan KD et al. The selective NK3 receptor agonist senktide excites a subpopulation of dopamine-sensitiveneurones in the rat substantia nigra pars compacta in vitro. Br J Pharmacol. 1992 Jan;105(1):3-5.
molnova catalog
related products
-
Talnetant
Talnetant is a selective competitive brain-penetrant NK3 receptor antagonist with the ability to modulate mesolimbic and mesocortical dopaminergic neurotransmission.
-
Lanepitant 2HCl
Lanepitant 2HCl is a non-peptide neurokinin-1 receptor antagonist with analgesic and anti-inflammatory activity.
-
Rolapitant hydrochlo...
Rolapitant (SCH619734) hydrochloride is a potent, selective, long-acting, and orally active neurokinin 1 (NK1) receptor antagonist with a K_i of 0.66 nM, which does not interact with CYP3A4 and demonstrates potent centrally-mediated anti-emetic activity in both acute and delayed ferret emesis models .
